Javier Velasco Hernández-Claveríe

Javier Velasco Hernández-Claveríe has a diverse work experience in the pharmaceutical and healthcare industry. Javier has held various positions at different companies, showcasing their expertise and skills in marketing, business development, and strategic planning.

Javier's most recent role is as the Onco-Hematology Commercial Director Iberia at Stemline Therapeutics, a position they started in 2023.

Prior to that, they worked at AstraZeneca from 2020 to 2023, where they held the positions of Franchise Head Lung & Immuno-Oncology, and Franchise Head Immuno-Oncology.

Javier also has experience as a Guest Professor in the Master Industria Farmaceutica y Parafarmaceutica program at CESIF from 2016 to 2020.

Before that, they worked at Ipsen as the Oncology Business Unit Director Iberia from 2018 to 2020.

From 2012 to 2018, Javier worked at Roche, where they held multiple roles including Marketing Unit Manager & ad-interim Sales Manager North Region, Marketing Unit Manager - Cancer Immunotherapy Franchise, Ad-interim Franchise Head - Cancer Immunotherapy Franchise, and Oncology Product Manager - Lung Franchise.

Javier also has experience as a Guest Professor in the Diploma Marketing Estratégico program at Universidad Complutense de Madrid in 2018.

Earlier in their career, Javier worked at Janssen, Pharmaceutical Companies of Johnson and Johnson, from 2009 to 2012. Javier held the positions of HIV Product Manager - Prezista and Business Analyst.

Prior to that, Javier worked at Chemo as a Business Development Analyst from 2007 to 2009, and at Sandoz Farmaceutica as a Business Intelligence Analyst from 2007 to 2007.

Javier Velasco Hernández-Claveríe completed their education with the following chronological information:

From 2013 to 2015, they attended IESE Business School - University of Navarra and obtained an Executive MBA Class of 2015 degree, specializing in MBA.

In 2012 to 2013, Javier attended IE Business School for the ISIS: Programa Desarrollo Talento Directivo (in company), which focused on Management.

From 2008 to 2009, they pursued a Master's degree in the Pharmaceutical and Parapharmaceutical Industry at CESIF.

Lastly, Javier Velasco Hernández-Claveríe attended Universidad CEU San Pablo from 2000 to 2006, where they earned a Licenciado degree in Pharmacy.